In the first comprehensive study of its kind, Fred Hutch scientists have mapped out how a critical design choice affects the activity and function of experimental CAR T-cell therapies. Their findings will inform the development of next-generation cancer immunotherapies so they work better for more patients.
The latest on the search for new biomarkers, better outcomes and cures for this deadly disease, which claims the lives of nearly 15,000 U.S. women a year.
Guideline-based care in clinical trials erased cancer death-rate disparities between rural and urban patients, according to a nationwide Hutch-led study.
Understanding how a common genetic mutation makes mouse small-cell lung tumors more vulnerable to certain cancer drugs offers hope for a precision medicine-approach to treatment.
Join the Climb to Fight Cancer in 2019 on one of our amazing, life-changing and research-funding expeditions. There are peaks for all levels of climbers. Learn more.
Supporting lifesaving research is now as simple as saying “Alexa, donate to Fred Hutch.” Alexa will guide you through an easy, fast and secure donation process. Don’t have an Alexa device? You can still donate anytime at fredhutch.org. Donate now.
If you are age 70 1/2 or older, consider fulfilling your required minimum distribution (RMD) through a charitable rollover gift from your Individual Retirement Account (IRA) to Fred Hutch. With your help, we can continue to pioneer research that saves thousands of lives around the world. Learn more.
